NXgenPort
PrivateLast Round
Seed
Nov 30, 2024
Total Funding Raised
$142,500
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NXgenPort operates in Healthcare & Life Sciences and is based in Saint Paul, Minnesota. Its latest recorded funding round was a Seed round in November 2024.
NXgenPort is a medical technology company that develops an implantable smart port device designed to provide remote physiological monitoring for cancer patients undergoing chemotherapy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NXgenPort Comparables
Compare NXgenPort with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PAVmed Inc. | 78% | |
| Neomend | 71% | |
| ICU Medical Inc | 71% |
For institutional investors. Book with your work email.
NXgenPort Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 30, 2024 | ||||
| Accelerator | Jul 28, 2023 | ||||
| Accelerator | Jun 6, 2023 | ||||
| Accelerator | Nov 10, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NXgenPort Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| CANCER FUND | Seed |
| Mayo Clinic Platform | Accelerator |
| mHUB | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 219% MoM.
- Jun 6, 2023
Received funding from MedTech Innovator.
For institutional investors. Book with your work email.
NXgenPort Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NXgenPort's valuation, stock price, and market status.
Is NXgenPort a public or private company?
NXgenPort is a private company.
What is the current stock price of NXgenPort?
NXgenPort is a private company, so its shares have no public market price. Caplight tracks NXgenPort's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NXgenPort worth (valuation)?
Valuation information for NXgenPort is not publicly available.
Can I buy NXgenPort stock?
NXgenPort shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NXgenPort's last funding round?
NXgenPort's most recent funding round was Seed on November 30, 2024.
Who are the main investors in NXgenPort?
Key investors in NXgenPort include MedTech Innovator, CANCER FUND, Mayo Clinic Platform, mHUB.
Will NXgenPort IPO soon?
No public IPO plans have been announced for NXgenPort.
How can I track NXgenPort secondary market activity?
Caplight tracks bids, offers, and trades in NXgenPort's shares on secondary markets.